Aripiprazole Oral Soluble Film(Lp Pharma)

阿立哌唑口溶膜（力品药业）

Report date: 2026/01/06 13:58:56

Base Information

Drug NameAripiprazole Oral Soluble Film(Lp Pharma)
Drug Alias Name阿利哌唑阿立派唑阿立哌唑口溶膜（2.2类改良型）LP088
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor agonistsDopamine D4 receptor antagonists +[9] 
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 1a (5-HT1a) receptorDopamine D2 receptor +[9] 
Therapy Area/IndicationsSchizophreniaAutistic DisorderDepressive Disorder, Major +[5] 
Global Approved IndicationsSchizophreniaAutistic DisorderDepressive Disorder, Major +[5] 
Approved Indications in ChinaSchizophrenia
Original Approved Country/TerritoryMainland China
Original Approved Date2023/12/29
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesXiamen Lp Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXiamen Lp Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophreniaAutistic DisorderDepressive Disorder, Major +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG